Amoxicillin
Aminopenicillin beta-lactam antibiotic with broad-spectrum activity against gram-positive and many gram-negative bacteria. Inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. Well absorbed orally (~90% bioavailability) regardless of food. Most prescribed antibiotic worldwide. Renally eliminated; dose adjust in renal impairment.
Projected serum levels — 500 mg, once daily
Maintenance schedule: 500 mg once daily (oral).
Modeled steady state after ~1 days: peak ≈ 197 mg, trough ≈ 0.000 mg body load. Population-based estimate over 15 days for a 500 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Antibiotic
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 1.1 h
- Common dose
- 500 mg
- Suggested maximum
- 3k mg/day
- Reference dose range
- 250–3k mg (single dose)
- Suggested cadence
- once daily
- Validated against
- 500 mg oral — Cmax 7.5 mg/L at 1.5 h
Documented interactions
-
warning
Warfarin (Coumadin) + Amoxicillin
Amoxicillin inhibits CYP2C9 and reduces vitamin K-producing gut flora; increases warfarin effect and INR.
-
caution
Ethinyl Estradiol + Amoxicillin
Broad-spectrum antibiotics may reduce enterohepatic recirculation of ethinyl estradiol by disrupting gut bacteria responsible for deconjugating EE glucuronides. This can transiently lower EE levels…
Serum checks 2 modeled interaction pairings for amoxicillin across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration
Definitive PK study establishing amoxicillin half-life of 1-1.5 hours, 90% oral bioavailability, dose-proportional pharmacokinetics, and predominantly renal elimination with 60-70% unchanged in urine.
-
Amoxicillin: a review of its use in the management of otitis media and other common infections
Comprehensive review establishing amoxicillin as first-line therapy for otitis media, sinusitis, UTIs, and lower respiratory infections with excellent oral absorption and tolerability.
2 published studies referenced in the app, each with a plain-language summary.